The following trials are currently enrolling:

TAYLORS OFFICE

1. New medication study for patients with either osteoarthritis or rheumatoid arthritis and cardiac risk factors such as hypertension, diabetes, etc.
2. New medication study for patients with a history of paroxysmal, persistant, or permanent atrial fibrillation (A-fib) within the past 12 months requiring VKA anticoagulant therapy (i.e., warfarin) and are at a moderate risk for stroke.
3. New medication study for patients with type 2 diabetes. Elligible subjects do not have to be currently taking any antidiabetic medication (i.e., metformin). However, patients that are unsuccesful in managing their type 2 diabetes with diet and exercise alone or taking only one antidiabetic medication or low-dose dual therapy may qualify.
4. New medication study for patients with type 2diabetes. Elligible patients do not have to be currently taking any antidiabetic medication or they may be on only one antidiabetic medication or low-dose dual therapy.
5. New medication study for patients with hypertension (high blood pressure) and type 2 diabetes.

ANDERSON OFFICE